Regulation of amyloid precursor protein (APP) phosphorylation and processing by p35/Cdk5 and p25/Cdk5 - PubMed (original) (raw)
Regulation of amyloid precursor protein (APP) phosphorylation and processing by p35/Cdk5 and p25/Cdk5
Feng Liu et al. FEBS Lett. 2003.
Free article
Abstract
The phosphorylation status of amyloid precursor protein (APP) at Thr668 is suggested to play a critical role in the proteolytic cleavage of APP, which generates either soluble APP(beta) (sAPP(beta)) and beta-amyloid peptide (Abeta), the major component of senile plaques in patient brains inflicted with Alzheimer's disease (AD), or soluble APP(alpha) (sAPP(alpha)) and a peptide smaller than Abeta. One of the protein kinases known to phosphorylate APP(Thr668) is cyclin-dependent kinase 5 (Cdk5). Cdk5 is activated by the association with its regulatory partner p35 or its truncated form, p25, which is elevated in AD brains. The comparative effects of p35 and p25 on APP(Thr668) phosphorylation and APP processing, however, have not been reported. In this study, we investigated APP(Thr668) phosphorylation and APP processing mediated by p35/Cdk5 and p25/Cdk5 in the human neuroblastoma cell line SH-SY5Y. Transient overexpression of p35 and p25 elicited distinct patterns of APP(Thr668) phosphorylation, specifically, p35 increasing the phosphorylation of both mature and immature APP, whereas p25 primarily elevated the phosphorylation of immature APP. Despite these differential effects on APP phosphorylation, both p35 and p25 overexpression enhanced the secretion of Abeta, sAPP(beta), as well as sAPP(alpha). These results confirm the involvement of Cdk5 in APP processing, and suggest that p35- and p25-mediated Cdk5 activities lead to discrete APP phosphorylation.
Similar articles
- p35/Cdk5 pathway mediates soluble amyloid-beta peptide-induced tau phosphorylation in vitro.
Town T, Zolton J, Shaffner R, Schnell B, Crescentini R, Wu Y, Zeng J, DelleDonne A, Obregon D, Tan J, Mullan M. Town T, et al. J Neurosci Res. 2002 Aug 1;69(3):362-72. doi: 10.1002/jnr.10299. J Neurosci Res. 2002. PMID: 12125077 - Activation of Cdk5/p25 and tau phosphorylation following chronic brain hypoperfusion in rats involves microRNA-195 down-regulation.
Sun LH, Ban T, Liu CD, Chen QX, Wang X, Yan ML, Hu XL, Su XL, Bao YN, Sun LL, Zhao LJ, Pei SC, Jiang XM, Zong DK, Ai J. Sun LH, et al. J Neurochem. 2015 Sep;134(6):1139-51. doi: 10.1111/jnc.13212. J Neurochem. 2015. PMID: 26118667 - The regulation of cyclin-dependent kinase 5 activity through the metabolism of p35 or p39 Cdk5 activator.
Hisanaga S, Saito T. Hisanaga S, et al. Neurosignals. 2003 Sep-Oct;12(4-5):221-9. doi: 10.1159/000074624. Neurosignals. 2003. PMID: 14673209 Review. - Glutamate treatment and p25 transfection increase Cdk5 mediated tau phosphorylation in SH-SY5Y cells.
Jämsä A, Bäckström A, Gustafsson E, Dehvari N, Hiller G, Cowburn RF, Vasänge M. Jämsä A, et al. Biochem Biophys Res Commun. 2006 Jun 23;345(1):324-31. doi: 10.1016/j.bbrc.2006.04.032. Epub 2006 May 6. Biochem Biophys Res Commun. 2006. PMID: 16678793 - Deregulated Cdk5 activity is involved in inducing Alzheimer's disease.
Shukla V, Skuntz S, Pant HC. Shukla V, et al. Arch Med Res. 2012 Nov;43(8):655-62. doi: 10.1016/j.arcmed.2012.10.015. Epub 2012 Nov 7. Arch Med Res. 2012. PMID: 23142263 Free PMC article. Review.
Cited by
- Fuzhisan Ameliorates the Memory Deficits in Aged SAMP8 Mice via Decreasing Aβ Production and Tau Hyperphosphorylation of the Hippocampus.
Zhang ZX, Zhao RP, Wang DS, Li YB. Zhang ZX, et al. Neurochem Res. 2016 Nov;41(11):3074-3082. doi: 10.1007/s11064-016-2028-4. Epub 2016 Aug 12. Neurochem Res. 2016. PMID: 27518086 - Phosphorylation Signaling in APP Processing in Alzheimer's Disease.
Zhang T, Chen D, Lee TH. Zhang T, et al. Int J Mol Sci. 2019 Dec 27;21(1):209. doi: 10.3390/ijms21010209. Int J Mol Sci. 2019. PMID: 31892243 Free PMC article. Review. - Inhibition of cyclin-dependent kinase 5 affects early neuroinflammatory signalling in murine model of amyloid beta toxicity.
Wilkaniec A, Gąssowska-Dobrowolska M, Strawski M, Adamczyk A, Czapski GA. Wilkaniec A, et al. J Neuroinflammation. 2018 Jan 4;15(1):1. doi: 10.1186/s12974-017-1027-y. J Neuroinflammation. 2018. PMID: 29301548 Free PMC article. - Therapeutic Mechanism and Key Alkaloids of Uncaria rhynchophylla in Alzheimer's Disease From the Perspective of Pathophysiological Processes.
Zeng P, Su HF, Ye CY, Qiu SW, Tian Q. Zeng P, et al. Front Pharmacol. 2021 Dec 15;12:806984. doi: 10.3389/fphar.2021.806984. eCollection 2021. Front Pharmacol. 2021. PMID: 34975502 Free PMC article. - p35 and Rac1 underlie the neuroprotection and cognitive improvement induced by CDK5 silencing.
Posada-Duque RA, López-Tobón A, Piedrahita D, González-Billault C, Cardona-Gomez GP. Posada-Duque RA, et al. J Neurochem. 2015 Jul;134(2):354-70. doi: 10.1111/jnc.13127. Epub 2015 May 4. J Neurochem. 2015. PMID: 25864429 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials